FullCircle Wealth’s Idexx Laboratories IDXX Stock Holding History

FullCircle Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$300K	Hold	415	–	–	0.11%	198
2025 Q2	$283K	Buy	+415	New	+$198K	0.11%	198

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

FullCircle Wealth's IDXX Position: Q3 2025 in Review

FullCircle Wealth held its Idexx Laboratories (IDXX) position steady in Q3 2025 at 415 shares worth $300K. The position accounts for 0.11% of the portfolio, ranked #198.

FullCircle Wealth first reported a position in IDXX in Q2 2025 and has held it in 2 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

FullCircle Wealth held 415 shares of Idexx Laboratories worth $300K as of Q3 2025.
FullCircle Wealth left its Idexx Laboratories share count unchanged in Q3 2025.
Idexx Laboratories made up 0.11% of FullCircle Wealth's portfolio in Q3 2025, its #198 holding.
FullCircle Wealth first reported a position in Idexx Laboratories in Q2 2025 and has held it in 2 quarters since.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on FullCircle Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.